This indicated TREM2‐mediated regulation of AD pathology via controlling microglial functions and corroborated a previous finding that the TREM2 loss‐of‐function variant R47H is associated with increased density of neuritic plaques and neurofibrillary tangles in multiple brain regions [13]. The gene discussed is TREM2; the disease is Alzheimer disease.